Last reviewed · How we verify
Familial lipoprotein lipase deficiency
Approved treatments
- Glybera · uniQure biopharma B.V.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Familial lipoprotein lipase deficiency patent landscape — cliff calendar, originator estates, attackable patents
- Familial lipoprotein lipase deficiency treatment landscape brief
- Familial lipoprotein lipase deficiency treatment updates RSS
Frequently asked questions about Familial lipoprotein lipase deficiency
What drugs treat Familial lipoprotein lipase deficiency?
Tracked treatments include Glybera.
What is the treatment for Familial lipoprotein lipase deficiency?
Standard treatment for Familial lipoprotein lipase deficiency includes Glybera. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Familial lipoprotein lipase deficiency patent cliff · Familial lipoprotein lipase deficiency CI report
- Treatment: Glybera · uniQure biopharma B.V.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing